בינוקריט 20000 יחבל  0.5 מל 이스라엘 - 히브리어 - Ministry of Health

בינוקריט 20000 יחבל 0.5 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 20000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

בינוקריט 3000 יחבל  0.3 מל 이스라엘 - 히브리어 - Ministry of Health

בינוקריט 3000 יחבל 0.3 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 3000 iu / 0.3 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

בינוקריט 40000 יחבל  1 מל 이스라엘 - 히브리어 - Ministry of Health

בינוקריט 40000 יחבל 1 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 40000 iu / 1 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

ליריקה 50 מג 이스라엘 - 히브리어 - Ministry of Health

ליריקה 50 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 50 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.

ליריקה 75 מג 이스라엘 - 히브리어 - Ministry of Health

ליריקה 75 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 75 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.

ליריקה 100 מג 이스라엘 - 히브리어 - Ministry of Health

ליריקה 100 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 100 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.

ליריקה 150 מג 이스라엘 - 히브리어 - Ministry of Health

ליריקה 150 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 150 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.

ליריקה 200 מג 이스라엘 - 히브리어 - Ministry of Health

ליריקה 200 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 200 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.

ליריקה 300 מג 이스라엘 - 히브리어 - Ministry of Health

ליריקה 300 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 300 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults. management of fibromyalgia.

ליריקה 225 מג 이스라엘 - 히브리어 - Ministry of Health

ליריקה 225 מג

pfizer pfe pharmaceuticals israel ltd - pregabalin - קפסולות - pregabalin 225 mg - pregabalin - pregabalin - lyrica is indicated for the treatment of peripheral and central neuropathic pain in adults.management of fibromyalgia.